Holen Sie sich die Stockscreener-App
61.26
2.09%
-1.31
Vorhandelsmarkt:
60.64
-0.62
-1.01%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$62.57
Offen:
$61.91
24-Stunden-Volumen:
1.88M
Relative Volume:
0.82
Marktkapitalisierung:
$9.54B
Einnahmen:
$1.17B
Nettoeinkommen (Verlust:
$150.71M
KGV:
65.17
EPS:
0.94
Netto-Cashflow:
$245.03M
1W Leistung:
-4.65%
1M Leistung:
-2.68%
6M Leistung:
+21.33%
1J Leistung:
-18.66%
1-Tages-Spanne:
$60.78
$62.38
1-Wochen-Bereich:
$60.48
$65.16
52-Wochen-Spanne:
$46.01
$80.80
Bio Techne Corp Stock (TECH) Company Profile
Firmenname
Bio Techne Corp
Sektor
Branche
Telefon
(612) 379-8854
Adresse
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Vergleichen Sie TECH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
61.26 | 9.74B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2025-07-09 | Eingeleitet | TD Cowen | Buy |
| 2025-05-30 | Eingeleitet | Wells Fargo | Overweight |
| 2025-04-09 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-02-08 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-02-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-08-28 | Eingeleitet | William Blair | Outperform |
| 2023-01-10 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Hochstufung | Stifel | Hold → Buy |
| 2021-01-25 | Bestätigt | The Benchmark Company | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-07-15 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Herabstufung | Stifel | Buy → Hold |
| 2020-05-14 | Eingeleitet | The Benchmark Company | Buy |
| 2020-01-08 | Fortgesetzt | Stephens | Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-02 | Hochstufung | Janney | Neutral → Buy |
| 2019-01-14 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-17 | Eingeleitet | Goldman | Neutral |
| 2018-06-15 | Eingeleitet | Argus | Buy |
| 2017-07-13 | Eingeleitet | Wells Fargo | Market Perform |
| 2017-02-09 | Eingeleitet | Citigroup | Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2013-09-20 | Hochstufung | Robert W. Baird | Neutral → Outperform |
Alle ansehen
Bio Techne Corp Aktie (TECH) Neueste Nachrichten
Bio-Techne Corp $TECH Shares Acquired by Teacher Retirement System of Texas - MarketBeat
What To Expect From Bio-Techne’s (TECH) Q3 Earnings - Yahoo! Finance UK
Bio-Techne Corp. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
Montanaro Asset Management Ltd Raises Holdings in Bio-Techne Corp $TECH - MarketBeat
Will Bio Techne Corporation benefit from macro trends2025 Key Highlights & Detailed Earnings Play Strategies - newser.com
How resilient is Bio Techne Corporation stock in market downturnsEarnings Overview Summary & Low Risk High Reward Ideas - newser.com
Can trapped investors hope for a rebound in Bio Techne CorporationForecast Cut & Smart Money Movement Alerts - newser.com
How to forecast Bio Techne Corporation trends using time seriesMarket Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics - Investing News Network
Why Bio Techne Corporation (TE1) stock could outperform next year2025 Market Overview & Trade Opportunity Analysis - newser.com
Is Bio Techne Corporation (TE1) stock overpriced at current multiplesLong Setup & Weekly Top Gainers Alerts - newser.com
How interest rate cuts could boost Bio Techne Corporation stockGlobal Markets & Daily Technical Forecast Reports - newser.com
Comparing Bio Techne Corporation in custom built stock radarsGold Moves & Weekly Chart Analysis and Guides - newser.com
Bio-Techne Corp $TECH Shares Bought by Geneva Capital Management LLC - MarketBeat
Simon Quick Advisors LLC Buys 6,354 Shares of Bio-Techne Corp $TECH - MarketBeat
Published on: 2025-11-02 04:30:59 - newser.com
Bessemer Group Inc. Sells 7,798 Shares of Bio-Techne Corp $TECH - MarketBeat
Is Bio Techne Corporation (TE1) stock a top hedge fund pickJuly 2025 Volume & Daily Entry Point Alerts - newser.com
Will Bio Techne Corporation stock benefit from sector rotationPortfolio Return Report & Consistent Income Trade Ideas - newser.com
Bio-Techne Corp. Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Asset Management One Co. Ltd. Has $264,000 Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp (TECH) Stock Forecasts - Yahoo Finance
Is Bio Techne Corporation stock a contrarian buyJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
Statistical indicators supporting Bio Techne Corporation’s strength2025 Risk Factors & Free Long-Term Investment Growth Plans - newser.com
Will Bio Techne Corporation (TE1) stock hit Wall Street targetsCEO Change & Verified Technical Signals - newser.com
Bio-Techne Corp (TECH) Stock forecasts - Yahoo! Finance UK
Bio-Techne Corporation (TECH) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Bio-Techne Corporation (TECH) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Bio-Techne Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Ownership Capital B.V. Cuts Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Why Bio Techne Corporation stock could benefit from AI revolution2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com
Bio-Techne Corp $TECH Shares Purchased by Nisa Investment Advisors LLC - MarketBeat
Heatmap analysis for Bio Techne Corporation and competitorsCPI Data & Proven Capital Preservation Methods - newser.com
Is Bio Techne Corporation (TE1) stock positioned for secular growthTrade Entry Report & Risk Adjusted Swing Trade Ideas - newser.com
How analysts revise price targets for Bio Techne Corporation (TE1) stockJuly 2025 Short Interest & AI Powered Market Entry Strategies - newser.com
Bio-Techne (TECH) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MSN
How Investors Are Reacting To Bio-Techne (TECH) Unveiling Its ProximityScope Spatial Biology Assay - Yahoo Finance
Bio-techne launches new assay for protein interaction visualization - Investing.com
Bio-Techne (NASDAQ: TECH) launches ProximityScope on BOND RX for protein interactions - Stock Titan
How to use Fibonacci retracement on Bio Techne CorporationWeekly Market Report & Growth Focused Stock Pick Reports - newser.com
Will Bio Techne Corporation price bounce be sustainable2025 Sector Review & Stock Portfolio Risk Control - newser.com
Bio-Techne Corp. stock underperforms Monday when compared to competitors - MarketWatch
Finanzdaten der Bio Techne Corp-Aktie (TECH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):